Results-driven researcher with a Ph.D. in Biophysics, showcasing a rich background in functional genomics, protein engineering, precision medicine, and deep mutational scanning screens. Spearheads assay development, design and execution of screens, and establishes training and robust best practices frameworks for pooled screening. Numerous publications in high-impact journals addressing critical aspects of cancer biology, DNA repair mechanisms, and therapeutic target identification. Dr. Persky has also been actively involved in mentorship, managing, and teaching. Highly experienced in cross-discipline collaboration, works well under pressure, excellent interpersonal skills.
-
Director, Functional GenomicsConstantiam Biosciences Jun 2024 - PresentCambridge, Massachusetts, United States -
Sr. Research ScientistAera Therapeutics Sep 2022 - Jan 2024Cambridge, Massachusetts, United StatesFocus: Developing and executing functional genomics and deep mutational scanning screens for proprietary proteins. As part of this, led assay development for growth and flow cytometry assays, designed and performed screens, and established training and documentation frameworks for pooled screening within the company. -
Research Scientist Ii, Genetic Perturbation PlatformBroad Institute Of Mit And Harvard May 2019 - Sep 2022Cambridge, Massachusetts, United StatesFocus: Deep Mutational Scanning, CRISPR, ORF, and Base Editing Screens, specializing in the design and interpretation of pooled mutagenesis screens for therapeutic targets. Collaborated and consulted on ~79 screening projects. Optimized screening strategy, troubleshooting, interpretation and quality controls. Initiated, designed and wrote a grant for experiments to pressure test new screening technologies. Led a monthly Screeners Meeting where collaborators could share their experiences with screening. Group: Genetic Perturbation Platform, Directed by David Root, PhD. -
Research Scientist I, Cancer ProgramBroad Institute Of Mit And Harvard Nov 2015 - May 2019Cambridge, Massachusetts, United StatesFocus: Identification of common ATP-competitive Inhibitor Resistance Sites in Kinases utilizing Deep Mutational Scanning pooled screening. Hypothesized, designed and tested comparative mutagenesis functional assays to identify drug resistance in cancer therapies for ultimate prevention. Supported multiple other Cancer Program projects as part of a highly collaborative team. Served as a committee member for the “Innovators in Cancer Research” seminar seriesGroup: Cancer Program, Group of Cory Johannessen, PhD. -
Postdoctoral Fellow/American Cancer Society Postdoctoral FellowMemorial Sloan Kettering Cancer Center Jul 2009 - Jul 2015New York, New York, United StatesFocus: Mechanisms of Fanconi Anemia Proteins in Crosslinked DNA Damage Repair. Purification, crystallization, biochemistry and interpretation of protein complexes of FancI and FancD2 in the presence of various types of DNA. Initiated work on Fanconi Anemia Mono-ubiquitination Complex from zebrafish and human constructs. Synthesized and purified covalently crosslinked DNA using click-chemistry for use in structural and biochemical experiments for Fanconi Anemia proteins and the Fan1 exonuclease. Executed skilled protein production from Bacteria, Insect, and Mammalian cell culturesGroup: Structural Biology Department, Lab of Nikola Pavletich, PhD -
Phd StudentBrandeis University Aug 2003 - Jun 2009Waltham, Massachusetts, United StatesFocus: Biochemistry of the DNA Replication and Nutritional Stress Response Protein ObgE. Purified untagged proteins, undertook GTPase assays, (p)ppGpp binding assays, and cell death assays with DNA damaging agents. Additionally used quantitative microscopy to follow DNA replication in wild type and mutant cells.Group: Biophysics and Biology Departments, Lab of Susan Lovett, PhD. -
Laboratory TechnicianDana-Farber Cancer Institute Sep 2001 - Jul 2003Boston, Massachusetts, United StatesFocus: Sequencing BRCA2 and FANCD2 Mutations in Fanconi Anemia Patients.Group: Molecular Diagnostics Laboratory, Lab of Edward Fox, PhD. -
Undergraduate ResearcherOberlin College Sep 1998 - May 2001Oberlin, Ohio, United StatesFocus: Copper-Pyrazine Compounds and Mn-12 thin film synthesis.Group: Chemistry Department, Lab of Sarah Stoll, PhD
Nicole S. Persky Education Details
-
Memorial Sloan Kettering Cancer CenterStructural Biology, Lab Of Nikola Pavletich, Phd -
Biophysics/Biology, Lab Of Susan Lovett, Phd -
Bachelor'S Degree, Chemistry With Honors, Lab Of Sarah Stoll, Phd.
Frequently Asked Questions about Nicole S. Persky
What company does Nicole S. Persky work for?
Nicole S. Persky works for Constantiam Biosciences
What is Nicole S. Persky's role at the current company?
Nicole S. Persky's current role is Director, Functional Genomics.
What schools did Nicole S. Persky attend?
Nicole S. Persky attended Memorial Sloan Kettering Cancer Center, Brandeis University, Oberlin College.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial